Holen Sie sich die Stockscreener-App
10.10
2.02%
0.20
Handel nachbörslich:
9.85
-0.25
-2.48%
Schlusskurs vom Vortag:
$9.90
Offen:
$9.88
24-Stunden-Volumen:
1.11M
Relative Volume:
1.41
Marktkapitalisierung:
$362.46M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-117.26M
KGV:
-3.0422
EPS:
-3.32
Netto-Cashflow:
$-99.96M
1W Leistung:
+22.42%
1M Leistung:
+37.79%
6M Leistung:
-32.44%
1J Leistung:
-26.60%
1-Tages-Spanne:
$9.655
$10.45
1-Wochen-Bereich:
$7.845
$12.01
52-Wochen-Spanne:
$3.61
$22.74
Biomea Fusion Inc Stock (BMEA) Company Profile
Firmenname
Biomea Fusion Inc
Sektor
Branche
Telefon
(650) 980-9099
Adresse
900 MIDDLEFIELD ROAD, REDWOOD CITY
Biomea Fusion Inc Stock (BMEA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-06-11 | Herabstufung | Truist | Buy → Hold |
| 2024-06-07 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2024-04-02 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-02-06 | Eingeleitet | Truist | Buy |
| 2023-07-27 | Eingeleitet | Scotiabank | Sector Outperform |
| 2023-06-26 | Herabstufung | Jefferies | Buy → Hold |
| 2023-05-12 | Eingeleitet | Barclays | Overweight |
| 2023-03-29 | Bestätigt | Oppenheimer | Outperform |
| 2023-03-28 | Bestätigt | H.C. Wainwright | Buy |
| 2023-02-24 | Eingeleitet | Citigroup | Buy |
| 2022-06-02 | Fortgesetzt | H.C. Wainwright | Buy |
| 2022-01-12 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-12-17 | Eingeleitet | Oppenheimer | Outperform |
| 2021-05-11 | Eingeleitet | JP Morgan | Overweight |
| 2021-05-11 | Eingeleitet | Jefferies | Buy |
| 2021-05-11 | Eingeleitet | Piper Sandler | Overweight |
Alle ansehen
Biomea Fusion Inc Aktie (BMEA) Neueste Nachrichten
Biomea Fusion: Recent Rally May Not Last, Despite Upcoming Data Catalysts - Seeking Alpha
We're Keeping An Eye On Biomea Fusion's (NASDAQ:BMEA) Cash Burn Rate - Simply Wall St
Biomea Fusion, Inc. (NASDAQ:BMEA) to Post Q1 2025 Earnings of ($0.82) Per Share, Capital One Financial Forecasts - MarketBeat
Biomea Fusion, Inc. (NASDAQ:BMEA) to Post Q1 2025 Earnings of ($0.82) Per Share, Capital One Financial Forecasts - Defense World
BMEA Stock Up 9% as FDA Lifts Clinical Hold on 2 Diabetes Studies - MSN
Biomea Fusion Sees Unusually Large Options Volume (NASDAQ:BMEA) - MarketBeat
Biomea Fusion (NASDAQ:BMEA) Stock Rating Upgraded by RODMAN&RENSHAW - MarketBeat
Scotiabank raises Biomea Fusion target on clinical progress By Investing.com - Investing.com South Africa
Biomea Fusion stock boosted by clinical progress in diabetes treatmentTruist - Investing.com
Scotiabank raises Biomea Fusion target on clinical progress By Investing.com - Investing.com Canada
Biomea’s diabetes studies back in business as FDA lifts hold - BioWorld Online
Wall Street SWOT: Biomea Fusion stock faces hurdles amid diabetes drug setback - Investing.com
Scotiabank raises Biomea Fusion target on clinical progress - Investing.com
Piper Sandler maintains Overweight on Biomea Fusion - Investing.com
Biomea Fusion PT raised by analysts as FDA lifts clinical holds for trials - Investing.com
FDA Removes Clinical Hold On Biomea Fusion's Early-Stage Trials For Potential Diabetes Candidate - AOL
Biomea upgraded by analysts after FDA lifts clinical hold (NASDAQ:BMEA) - Seeking Alpha
FDA Removes Clinical Hold On Biomea Fusion's Early-Stage Trials For Potential Diabetes Candidate - Benzinga
IonQ, Biomea Fusion, Rocket Lab USA And Other Big Stocks Moving Higher On Friday - MSN
Scotiabank raises Biomea Fusion target on clinical progress By Investing.com - Investing.com UK
Biomea Fusion (NASDAQ:BMEA) Price Target Raised to $9.00 - MarketBeat
Biomea’s stock bounces back as FDA lifts clinical hold on diabetes trials - Yahoo Finance
Biomea’s stock bounces back as FDA lifts clinical hold on diabetes trials - Pharmaceutical Technology
IonQ, Biomea Fusion, Rocket Lab USA And Other Big Stocks Moving Higher On Friday - Benzinga
BMEA Stock Up 9% as FDA Lifts Clinical Hold on 2 Diabetes Studies - Zacks Investment Research
BMEA Stock Up 9% as FDA Lifts Clinical Hold on 2 Diabetes Studies - Yahoo Finance
Biomea Fusion (NASDAQ:BMEA) Stock Rating Upgraded by Truist Financial - MarketBeat
Biomea Fusion stock boosted by clinical progress in diabetes treatmentTruist - Investing.com India
Truist Securities Upgrades Biomea Fusion (BMEA) - MSN
US FDA lifts clinical hold on Biomea's diabetes trials after safety review - Reuters
US FDA lifts clinical hold on Biomea’s diabetes trials - WIBQ
US FDA lifts clinical hold on Biomea’s diabetes trials - WSAU
US FDA lifts clinical hold on Biomea’s diabetes trials - WNWN-FM
US FDA lifts clinical hold on Biomea’s diabetes trials - WKZO
Biomea stock jumps 9% after FDA lifts hold on Phase 1/2 study (NASDAQ:BMEA) - Seeking Alpha
Biomea Fusion upgraded to Buy from Neutral at Rodman & Renshaw - TipRanks
Biomea Fusion: FDA Lifts Hold on Diabetes-Treatment Trials - MarketWatch
FDA Lifts Clinical Hold on BMF-219 in Type 2 and Type 1 Diabetes Trials - GlobeNewswire
FDA Lifts Clinical Hold on BMF-219 in Type 2 and Type 1 Diabetes Trials - GlobeNewswire Inc.
DRW Securities LLC Takes Position in Biomea Fusion, Inc. (NASDAQ:BMEA) - Defense World
Bank of New York Mellon Corp Buys 29,400 Shares of Biomea Fusion, Inc. (NASDAQ:BMEA) - Defense World
(BMEA) Investment Report - Stock Traders Daily
Short Interest in Biomea Fusion, Inc. (NASDAQ:BMEA) Expands By 7.8% - Defense World
Biomea Fusion, Inc. (NASDAQ:BMEA) Short Interest Update - MarketBeat
(BMEA) Investment Analysis - Stock Traders Daily
Biomea Fusion, Inc. (NASDAQ:BMEA) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Biomea Fusion, Inc. (NASDAQ:BMEA) Receives Average Rating of “Moderate Buy” from Brokerages - Defense World
Biomea Fusion, Inc. (NASDAQ:BMEA) Sees Large Decline in Short Interest - MarketBeat
Biomea Fusion, Inc. Expected to Post Q3 2024 Earnings of ($1.08) Per Share (NASDAQ:BMEA) - MarketBeat
Capital One Financial Comments on Biomea Fusion, Inc.’s Q3 2024 Earnings (NASDAQ:BMEA) - Defense World
iA Global Asset Management Inc. Acquires New Position in Biomea Fusion, Inc. (NASDAQ:BMEA) - Defense World
Finanzdaten der Biomea Fusion Inc-Aktie (BMEA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.05%
4.86%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):